News | March 31, 2023
Evonik starts construction of US$220 million lipid innovation center in Lafayette
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Time to combine innovation, access and technology to deliver positive patient outcomes
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
FDA also accepts a separate supplemental application to extend prophylaxis with PREVYMIS to 200 days in certain HSCT recipients
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
Subscribe To Our Newsletter & Stay Updated
